alexa Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures.
Infectious Diseases

Infectious Diseases

Journal of Clinical Infectious Diseases & Practice

Author(s): Salgado CD, Mauldin PD, Fogle PJ, Bosso JA, Salgado CD, Mauldin PD, Fogle PJ, Bosso JA

Abstract Share this page

Abstract BACKGROUND: In October 2004, our Clostridium difficile infection (CDI) rate increased (relative risk, 3.51; 95\% confidence interval: 2.96-4.16) from a baseline rate of 1.35 per 1000 patient-days. We describe the outbreak, the relationship between antibiotic use and CDI, and the effect of enhanced infection control measures (EICM) on CDI. METHODS: Rates were calculated as positive C difficile toxin A or B tests among patients with nosocomial diarrhea per 1000 patient-days (duplicates removed). Antibiotic use was calculated as defined daily dose per 1000 patient-days. EICM consisted of (1) placing patients with diarrhea into empiric Contact Precautions, (2) cleaning with a bleach product in areas with CDI patients, and (3) requiring soap and water hand hygiene when caring for CDI patients. CDI rates were analyzed by chi(2) for trend. Time series methodology was used to examine the association between CDI and antibiotic use. RESULTS: During the outbreak (October 2004-May 2005), we observed 144 excess cases of CDI. The CDI rate decreased after EICM were implemented (P < .0001) and has been maintained for 36 months beyond the outbreak. Multivariate analysis revealed positive associations between CDI rates and cefazolin use (P = .008) and levofloxacin/gatifloxacin use (P = .015). CONCLUSION: Despite an association between some antibiotic use and CDI rates, we achieved sustained control of an outbreak using EICM without formulary changes or new antibiotic control policies. This suggests that patient-to-patient spread may be a more important cause of increased CDI rates. This article was published in Am J Infect Control and referenced in Journal of Clinical Infectious Diseases & Practice

Relevant Expert PPTs

Relevant Speaker PPTs

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version